Barclays PLC Grows Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Barclays PLC lifted its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 180.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 310,194 shares of the company's stock after buying an additional 199,454 shares during the period. Barclays PLC owned approximately 0.18% of Option Care Health worth $9,708,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Wellington Management Group LLP boosted its stake in Option Care Health by 15.5% during the third quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company's stock worth $310,650,000 after buying an additional 1,328,326 shares during the period. FMR LLC boosted its holdings in Option Care Health by 134.0% in the third quarter. FMR LLC now owns 7,516,448 shares of the company's stock valued at $235,265,000 after purchasing an additional 4,304,896 shares during the period. Westfield Capital Management Co. LP grew its stake in Option Care Health by 10.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company's stock worth $203,204,000 after purchasing an additional 599,589 shares in the last quarter. State Street Corp increased its holdings in Option Care Health by 1.4% during the 3rd quarter. State Street Corp now owns 6,257,172 shares of the company's stock worth $195,849,000 after purchasing an additional 83,395 shares during the period. Finally, Thrivent Financial for Lutherans raised its position in Option Care Health by 7.4% in the 3rd quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company's stock valued at $183,541,000 after purchasing an additional 404,811 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.

Option Care Health Price Performance

Option Care Health stock traded down $0.04 during mid-day trading on Tuesday, reaching $23.42. The company had a trading volume of 2,857,817 shares, compared to its average volume of 1,569,037. The stock's 50-day simple moving average is $25.20 and its 200-day simple moving average is $28.37. The company has a market capitalization of $3.99 billion, a P/E ratio of 19.68, a P/E/G ratio of 2.45 and a beta of 1.33. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $34.63.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the stock. UBS Group initiated coverage on shares of Option Care Health in a report on Thursday, December 5th. They issued a "neutral" rating and a $26.00 target price on the stock. JMP Securities increased their price objective on Option Care Health from $36.00 to $37.00 and gave the company a "market outperform" rating in a report on Monday, September 30th. Bank of America cut Option Care Health from a "buy" rating to a "neutral" rating and decreased their target price for the stock from $43.00 to $29.00 in a research note on Wednesday, October 30th. Barrington Research cut their price objective on shares of Option Care Health from $40.00 to $32.00 and set an "outperform" rating on the stock in a report on Thursday, October 31st. Finally, The Goldman Sachs Group cut shares of Option Care Health from a "buy" rating to a "neutral" rating and lowered their target price for the company from $38.00 to $27.00 in a report on Monday, November 4th. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and an average target price of $30.14.

Insider Buying and Selling

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the stock in a transaction dated Friday, November 8th. The shares were acquired at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares of the company's stock, valued at $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. 0.64% of the stock is currently owned by insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.